ReportLinker Find Industry reports, Company profiles and Market Statistics >> Get this Report Now by email! Infectious Vaccines Partnering Terms and Agreements Published on December 2013 Report Summary The Infectious Vaccines Partnering Terms and agreements report provides a detailed understanding and analysis of how and why companies enter infectious vaccines partnering deals. The majority of deals are development stage whereby the licensee obtains a right or an option right to license the licensors vaccine technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. The report also includes adjuvant deals and alliances. This report provides details of the latest infectious vaccines agreements announced in the healthcare sectors. Understanding the flexibility of a prospective partner's negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered ' contract documents provide this insight where press releases and databases do not. This report contains a comprehensive listing of all infectious vaccines partnering deals announced since January 2007, including financial terms where available, including over 700 links to online deal records of actual infectious vaccines partnering deals as disclosed by the deal parties. In addition, where available, records include contract documents as submitted to the Securities Exchange Commission by companies and their partners. Contract documents provide the answers to numerous questions about a prospective partner's flexibility on a wide range of important issues, many of which will have a significant impact on each party's ability to derive value from the deal. For example, analyzing actual company deals and agreements allows assessment of the following: What is actually granted by the agreement to the partner company' What exclusivity is granted' What are the precise rights granted or optioned' What is the payment structure for the deal' How are sales and payments audited' What is the deal term' How are the key terms of the agreement defined' How are IPRs handled and owned' Who is responsible for commercialization' Who is responsible for development, supply, and manufacture' How is confidentiality and publication managed' How are disputes to be resolved' Under what conditions can the deal be terminated' What happens when there is a change of ownership' What sublicensing and subcontracting provisions have been agreed' Which boilerplate clauses does the company insist upon' Which boilerplate clauses appear to differ from partner to partner or deal type to deal type' Which jurisdiction does the company insist upon for agreement law' Infectious Vaccines Partnering Terms and Agreements (From Issuu) Page 1/23
23
Embed
Infectious Vaccines Partnering Terms and Agreements
The Infectious Vaccines Partnering Terms and agreements report provides a detailed understanding and analysis of how and why companies enter infectious vaccines partnering deals. The majority of deals are development stage whereby the licensee obtains a right or an option right to license the licensors vaccine technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. The report also includes adjuvant deals and alliances. This report provides details of the latest infectious vaccines agreements announced in the healthcare sectors. Understanding the flexibility of a prospective partner's negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered ' contract documents provide this insight w...
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
ReportLinker Find Industry reports, Company profilesand Market Statistics
>> Get this Report Now by email!
Infectious Vaccines Partnering Terms and Agreements
Published on December 2013
Report Summary
The Infectious Vaccines Partnering Terms and agreements report provides a detailed understanding and analysis of how and why
companies enter infectious vaccines partnering deals. The majority of deals are development stage whereby the licensee obtains a
right or an option right to license the licensors vaccine technology. These deals tend to be multicomponent, starting with collaborative
R&D, and commercialization of outcomes. The report also includes adjuvant deals and alliances.
This report provides details of the latest infectious vaccines agreements announced in the healthcare sectors.
Understanding the flexibility of a prospective partner's negotiated deals terms provides critical insight into the negotiation process in
terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the
payments clauses, the devil is in the detail in terms of how payments are triggered ' contract documents provide this insight where
press releases and databases do not.
This report contains a comprehensive listing of all infectious vaccines partnering deals announced since January 2007, including
financial terms where available, including over 700 links to online deal records of actual infectious vaccines partnering deals as
disclosed by the deal parties. In addition, where available, records include contract documents as submitted to the Securities
Exchange Commission by companies and their partners.
Contract documents provide the answers to numerous questions about a prospective partner's flexibility on a wide range of important
issues, many of which will have a significant impact on each party's ability to derive value from the deal.
For example, analyzing actual company deals and agreements allows assessment of the following:
What is actually granted by the agreement to the partner company'
What exclusivity is granted'
What are the precise rights granted or optioned'
What is the payment structure for the deal'
How are sales and payments audited'
What is the deal term'
How are the key terms of the agreement defined'
How are IPRs handled and owned'
Who is responsible for commercialization'
Who is responsible for development, supply, and manufacture'
How is confidentiality and publication managed'
How are disputes to be resolved'
Under what conditions can the deal be terminated'
What happens when there is a change of ownership'
What sublicensing and subcontracting provisions have been agreed'
Which boilerplate clauses does the company insist upon'
Which boilerplate clauses appear to differ from partner to partner or deal type to deal type'
Which jurisdiction does the company insist upon for agreement law'
Infectious Vaccines Partnering Terms and Agreements (From Issuu) Page 1/23
ReportLinker Find Industry reports, Company profilesand Market Statistics
>> Get this Report Now by email!Fax Order Form To place an order via fax simply print this form, fill in the information below and fax the completed form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56 Asia, Oceania and America : + 1 (805) 617 17 93
If you have any questions please visit http://www.reportlinker.com/notify/contact Order Information Please verify that the product information is correct and select the format(s) you require.
Product Formats Please select the product formats and the quantity you require.
Contact Information Please enter all the information below in BLOCK CAPITALS Title: Mr Mrs Dr Miss Ms Prof First Name: _____________________________ Last Name: __________________________________ Email Address: __________________________________________________________________________ Job Title: __________________________________________________________________________ Organization: __________________________________________________________________________ Address: __________________________________________________________________________ City: __________________________________________________________________________ Postal / Zip Code: __________________________________________________________________________ Country: __________________________________________________________________________ Phone Number: __________________________________________________________________________ Fax Number: __________________________________________________________________________
Infectious Vaccines Partnering Terms and Agreements
1 User License--USD 1 995.00 Quantity: _____
CD-ROM--USD 2 495.00 Quantity: _____
2-5 User License--USD 2 995.00 Quantity: _____
Site License--USD 5 995.00 Quantity: _____
Corporate License--USD 9 975.00 Quantity: _____
Infectious Vaccines Partnering Terms and Agreements (From Issuu) Page 22/23